|
1
|
Firestein GS: Evolving concepts of
rheumatoid arthritis. Nature. 423:356–361. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bottini N and Firestein GS: Duality of
fibroblast-like synoviocytes in RA: Passive responders and
imprinted aggressors. Nat Rev Rheumatol. 9:24–33. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miossec P: Rheumatoid arthritis: Still a
chronic disease. Lancet. 381:884–886. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
O'Connell RM, Rao DS and Baltimore D:
microRNA regulation of inflammatory responses. Annu Rev Immunol.
30:295–312. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stanczyk J, Pedrioli DM, Brentano F,
Sanchez-Pernaute O, Kolling C, Gay RE, Detmar M, Gay S and Kyburz
D: Altered expression of MicroRNA in synovial fibroblasts and
synovial tissue in rheumatoid arthritis. Arthritis Rheum.
58:1001–1009. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu X, Li Y, Shen H, Li H, Long L, Hui L
and Xu W: miR-137 inhibits the proliferation of lung cancer cells
by targeting Cdc42 and Cdk6. FEBS Lett. 587:73–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng Y, Li Y, Liu D, Zhang R and Zhang J:
miR-137 effects on gastric carcinogenesis are mediated by targeting
Cox-2-activated PI3K/AKT signaling pathway. FEBS Lett.
588:3274–3281. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang H and Li H: miR-137 inhibits renal
cell carcinoma growth in vitro and in vivo. Oncol Lett. 12:715–720.
2016.PubMed/NCBI
|
|
13
|
Zhao Y, Li Y, Lou G, Zhao L, Xu Z, Zhang Y
and He F: MiR-137 targets estrogen-related receptor alpha and
impairs the proliferative and migratory capacity of breast cancer
cells. PLoS One. 7:e391022012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Geekiyanage H and Chan C:
MicroRNA-137/181c regulates serine palmitoyltransferase and in turn
amyloid β, novel targets in sporadic Alzheimer's disease. J
Neurosci. 31:14820–14830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Siegert S, Seo J, Kwon EJ, Rudenko A, Cho
S, Wang W, Flood Z, Martorell AJ, Ericsson M, Mungenast AE and Tsai
LH: Addendum: The schizophrenia risk gene product miR-137 alters
presynaptic plasticity. Nat Neurosci. 19:11152016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brand DD, Latham KA and Rosloniec EF:
Collagen-induced arthritis. Nat Protoc. 2:1269–1275. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Y, Xian PF, Yang L and Wang SX:
MicroRNA-21 promotes proliferation of fibroblast-like synoviocytes
through mediation of NF-κB nuclear translocation in a rat model of
collagen-induced rheumatoid arthritis. Biomed Res Int.
2016:92790782016.PubMed/NCBI
|
|
18
|
Zhang H and Li H: miR-137 inhibits renal
cell carcinoma growth in vitro and in vivo. Oncol Lett. 12:715–720.
2016.PubMed/NCBI
|
|
19
|
Li Z, Wang W, Xu H, Ning Y, Fang W, Liao
W, Zou J, Yang Y and Shao N: Effects of altered CXCL12/CXCR4 axis
on BMP2/Smad/Runx2/Osterix axis and osteogenic gene expressions
during osteogenic differentiation of MSCs. Am J Transl Res.
9:1680–1693. 2017.PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pablos JL, Santiago B, Galindo M, Torres
C, Brehmer MT, Blanco FJ and García-Lázaro FJ: Synoviocyte-derived
CXCL12 is displayed on endothelium and induces angiogenesis in
rheumatoid arthritis. J Immunol. 170:2147–2152. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang S and Yang Y: Downregulation of
microRNA-221 decreases migration and invasion in fibroblast-like
synoviocytes in rheumatoid arthritis. Mol Med Rep. 12:2395–2401.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li XF, Shen WW, Sun YY, Li WX, Sun ZH, Liu
YH, Zhang L, Huang C, Meng XM and Li J: MicroRNA-20a negatively
regulates expression of NLRP3-inflammasome by targeting TXNIP in
adjuvant-induced arthritis fibroblast-like synoviocytes. Joint Bone
Spine. 83:695–700. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Choy EH and Panayi GS: Cytokine pathways
and joint inflammation in rheumatoid arthritis. N Engl J Med.
344:907–916. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stokes MB, Foster K, Markowitz GS,
Ebrahimi F, Hines W, Kaufman D, Moore B, Wolde D and D'Agati VD:
Development of glomerulonephritis during anti-TNF-α therapy for
rheumatoid arthritis. Nephrol Dial Transplant. 20:1400–1406. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hashizume M and Mihara M: The roles of
interleukin-6 in the pathogenesis of rheumatoid arthritis.
Arthritis. 2011:7656242011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Croft M: The TNF family in T cell
differentiation and function-unanswered questions and future
directions. Semin Immunol. 26:183–190. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schenten D, Nish SA, Yu S, Yan X, Lee HK,
Brodsky I, Pasman L, Yordy B, Wunderlich FT, Brüning JC, et al:
Signaling through the adaptor molecule MyD88 in CD4+ T cells is
required to overcome suppression by regulatory T cells. Immunity.
40:78–90. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nish SA, Schenten D, Wunderlich FT, Pope
SD, Gao Y, Hoshi N, Yu S, Yan X, Lee HK, Pasman L, et al: T
cell-intrinsic role of IL-6 signaling in primary and memory
responses. Elife. 3:e019492014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vicente-Manzanares M, Montoya MC, Mellado
M, Frade JM, del Pozo MA, Nieto M, de Landazuri MO, Martínez-A C
and Sánchez-Madrid F: The chemokine SDF-1α triggers a chemotactic
response and induces cell polarization in human B lymphocytes. Eur
J Immunol. 28:2197–2207. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nagasawa T, Tachibana K and Kishimoto T: A
novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: Their
functions in development, hematopoiesis and HIV infection. Semin
Immunol. 10:179–185. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Santiago B, Calonge E, Del Rey MJ,
Gutierrez-Cañas I, Izquierdo E, Usategui A, Galindo M, Alcamí J and
Pablos JL: CXCL12 gene expression is upregulated by hypoxia and
growth arrest but not by inflammatory cytokines in rheumatoid
synovial fibroblasts. Cytokine. 53:184–190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dong S, Jin M, Li Y, Ren P and Liu J:
miR-137 acts as a tumor suppressor in papillary thyroid carcinoma
by targeting CXCL12. Oncol Rep. 35:2151–2158. 2016. View Article : Google Scholar : PubMed/NCBI
|
